We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




DNA Synthesis Visualized in Whole Animals

By LabMedica International staff writers
Posted on 03 Jan 2012
Swiss scientists have discovered a new substance for labeling and visualization of DNA synthesis in vivo in whole animals. More...


Applications for this technique include identifying the sites of virus infections and cancer growth, due to the profusion of DNA replication in these tissues. This strategy should therefore lead to new applications in drug development.

Interactions of biologic macromolecules are the fundamental bases of living systems. Biologic macromolecules are synthesized in living cells by linking many small molecules together. Naturally occurring macromolecules include genetic materials (DNA) and proteins. A precise determination of the synthesis of these macromolecules in whole animals is a basic prerequisite for better understanding biologic systems, and for the development of new therapeutic strategies.

To visualize the synthesis of biomolecules in living organisms, synthetic small molecules can be added to and integrated by the cell’s own biosynthetic processes. Consequently, the engineered biomolecules containing the synthetic units can be selectively labeled with fluorescent compounds. Until now, this approach had one major drawback: the substances used for labeling were toxic and caused cell death.

Anne Neef, a PhD student from the Institute of Organic Chemistry at the University of Zurich (Switzerland), has devised a new compound that can replace the natural nucleoside thymidine in DNA biosynthesis. This fluorinated nucleoside called F-ara-Edu labels DNA with little or no impact on genome function in living cells and even whole animals. F-ara-Edu is less toxic than previously reported compounds used for DNA labeling and it can be detected with greater sensitivity.

F-ara-Edu is therefore perfectly suited for experiments aimed at “birth dating” DNA synthesis in vivo. “As a demonstration of this, F-ara-Edu was injected into Zebrafish eggs immediately after fertilization. Following development and hatching of the fish, the very first cells undergoing differentiation in embryonic development could be identified,” explained Ms. Neef’s research advisor, Prof. Nathan Luedtke. “By visualizing new DNA synthesis in whole animals, the sites of virus infection and cancerous growth can be identified due to the abundance of DNA replication in these tissues,” added Prof. Luedtke. This strategy should therefore lead to new strategies in drug development.

Related Links:

University of Zurich



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Blood Glucose Test Strip
AutoSense Test
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researchers identified SARS-CoV-2 protein fragments within extracellular vesicles in the blood of long COVID patients (Photo courtesy of Shutterstock)

Blood Biomarker Test Could Confirm Long COVID Diagnosis

Long COVID remains a diagnostic challenge, with clinicians currently relying on a collection of symptoms that appear 12 weeks or more after SARS-CoV-2 infection. No blood tests or biomarkers currently... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Insights into sarcomatoid renal cell carcinoma point to broader use of common immunotherapies (Photo courtesy of Salgia NJ et al., Cancer Cell, 2025)

Novel Gene Signature Predicts Immunotherapy Response in Advanced Kidney Cancers

Sarcomatoid renal cell carcinoma (sRCC) is a rare, aggressive form of kidney cancer comprising about 5% of cases and is typically diagnosed at late stages. Resistant to most therapies, it has shown unusually... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.